自拍无码精品一区二区|亚洲А∨天堂久久精品|国产日韩欧美一区二区视|亚洲av高清dvd丝袜|中文一级无码黄片精品视频|亚洲无码网站在线免费观看|免费无码又爽又刺激又污又黄|成人免费无码婬片在线观看免费

  • <tfoot id="icskm"></tfoot>
  • <code id="icskm"><xmp id="icskm"></xmp></code>
  • <li id="icskm"><input id="icskm"></input></li>
    <code id="icskm"></code>
  • <cite id="icskm"><center id="icskm"></center></cite><button id="icskm"><bdo id="icskm"></bdo></button><code id="icskm"></code>
  • <cite id="icskm"><pre id="icskm"></pre></cite>
    <button id="icskm"></button>
  • <rt id="icskm"><pre id="icskm"></pre></rt>
    <cite id="icskm"></cite>
    <li id="icskm"></li>
    <button id="icskm"><input id="icskm"></input></button>
  • 159-2642-3062 027-65317797
    服務(wù)熱線(工作日:9:00-17:30)

    瀏覽量: 576

    • 產(chǎn)品名稱: Research Grade Adalimumab ( 阿達(dá)木單抗 )
    • 產(chǎn)品貨號(hào): CSD00093
    • 貨期: 現(xiàn)貨
    • 價(jià)格與訂購(gòu): 598
    • 數(shù)量:
      庫(kù)存: 100
    • 規(guī)格: 100μg 1mg
    • 產(chǎn)品信息
    • 如何訂購(gòu)
      貨號(hào)(Catalog No.)
      CSD00093
      通用名INN
      Adalimumab
      純度(Purity)
      >95%
      濃度( Concentration)
      1mg/ml
      Formulation
      PBS buffer PH7.5
      Source
      CHO cells
      內(nèi)毒素(Endotoxin level)
      Please contact with the lab for this information.
      產(chǎn)品描述(Description)
      Adalimumab is a subcutaneously administered biological disease modifier for the treatment of rheumatoid arthritis and other chronic debilitating diseases mediated by tumor necrosis factor 2, 3. It was originally launched by Abbvie in the U.S. and approved in 2002 by the FDA 1. This drug is frequently known as Humira. It is produced by recombinant DNA technology using a mammalian cell expression system. This drug is available in a prefilled syringe form and convenient pen form for subcutaneous self-administered doses 1. A new biosimilar to adalimumab, named adalimumab-adaz, was approved by the FDA on October 31, 2018. This biosimilar is known as Hyrimoz, and is a trademark of Novartis AG 9.
      別名(Alternative names)
      D2E7
      靶點(diǎn);物種(Specificity target name;species)
      TNFSF2/TNF-alpha/TNFA[Homo sapiens]
      活性研究(體外/體內(nèi)研究)(Activity in vitro)
      Adalimumab (anti-TNF-alpha) blocks the interaction of TNF with the p55 and p75 cell surface TNF receptors, thereby neutralising the activity of this cytokine. Through its anti-TNF actions, adalimumab reduces concentrations of matrix metalloproteases (MMP-1 and -3) and other markers of cartilage and synovium turnover, reduces of matrix metalloproteases (MMP-1 and -3) and other markers of cartilage and synovium turnover, and reduces concentrations of acute phase reactants of inflammation (C-reactive protein [CRP] and erythrocyte sedimentation rate [ESR]) and serum cytokines (IL-1β mRNA, IL-1 receptor antagonist, IL-6).
      種類(Species)
      Homo sapiens
      受體鑒定(Receptor identification)
      IgG1-kappa
      分子量(MV)
      148000.00 Da
      CAS
      331731-18-1
      存儲(chǔ)條件(Storage)
      Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
      Store at +4°C short term (1-2 weeks).
      Store at -20 °C 12 months.
      Store at -80°C long term.
      Note
      For research use only .
    乐安县| 裕民县| 确山县| 康定县| 玉溪市| 广德县| 阿拉善盟| 黔西县| 襄城县| 晋宁县| 河东区| 海盐县| 湛江市| 咸丰县| 左贡县| 巨鹿县| 和龙市| 泸州市| 西平县| 庆阳市| 马公市| 宜春市| 开阳县| 二连浩特市| 谷城县| 沛县| 蒲城县| 安塞县| 石林| 永泰县| 托克逊县| 中超| 五指山市| 云梦县| 咸丰县| 邳州市| 张北县| 华安县| 临汾市| 镇平县| 茂名市|